Sinovac Biotech (SVA) EBITDA (2009 - 2024)
Sinovac Biotech (SVA) EBITDA from Dec 31, 2009 to Dec 31, 2024. The TTM Sinovac Biotech (SVA) EBITDA is -$395M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Sinovac Biotech (SVA) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 1 Year | -28.97% |
Annual EBITDA change of Sinovac Biotech (SVA)
| Year | EBITDA | Change |
|---|---|---|
| 2024 | -$395M | -28.97% |
| 2023 | -$557M | +56.21% |
| 2022 | -$356M | -102.01% |
| 2021 | $18B | +7971.23% |
| 2020 | $219M | +199.89% |
| 2019 | $73M | +45.70% |
| 2018 | $50M | +0.28% |
| 2017 | $50M | +798.74% |
| 2016 | $5.57M | -44.02% |
| 2015 | $9.95M | +2.37% |
| 2014 | $9.72M | -37.73% |
| 2013 | $16M | -193.70% |
| 2012 | -$17M | -303.17% |
| 2011 | $8.20M | -203.93% |
| 2010 | -$7.89M | -117.77% |
| 2009 | $44M | N/A |